CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in GILD — Gilead Sciences, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,140,294,678
+$157,541,274 QoQ
Shares Held
8,181,780
+2.2% QoQ
Ownership
0.659%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.9928132997954.ToString("F0")%
Shared 0.ToString("F0")%
None 0.007186700204600954.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $30,098,800,763 across 16 Drug Manufacturers - General names. GILD ranks #8 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
49,765,225 | $5,986,258,914 | |
| 2 | LLY |
ELI LILLY & Co
|
5,897,450 | $5,424,297,586 | |
| 3 | JNJ |
Johnson & Johnson
|
19,177,219 | $4,687,679,411 | |
| 4 | AMGN |
Amgen Inc
|
12,773,386 | $4,494,315,864 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
61,115,373 | $3,706,647,372 | |
| 6 | ABBV |
AbbVie Inc.
|
12,967,398 | $2,820,279,389 | |
| 7 | PFE |
Pfizer Inc
|
51,891,636 | $1,457,117,138 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
8,181,780 | $1,140,294,678 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,140,294,678 | 8,181,780 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $982,753,404 | 8,006,790 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $880,325,460 | 7,930,860 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $886,968,204 | 8,000,074 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $897,576,637 | 8,010,501 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $739,216,696 | 8,002,779 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $650,009,424 | 7,752,975 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $516,497,109 | 7,528,015 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $539,651,795 | 7,367,260 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $589,873,423 | 7,281,489 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $539,118,884 | 7,194,007 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $558,927,439 | 7,252,205 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $614,114,817 | 7,401,649 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $648,092,724 | 7,549,129 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $457,885,820 | 7,422,367 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $440,130,281 | 7,120,697 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $431,097,632 | 7,251,432 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $524,971,026 | 7,230,010 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $493,234,319 | 7,061,336 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $478,420,756 | 6,947,731 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $414,251,026 | 6,409,578 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $380,699,096 | 6,534,485 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $411,718,173 | 6,515,559 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $531,371,799 | 6,906,314 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $532,811,454 | 7,126,959 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||